Key terms > Contact us > Career opportunities > For the media > Corporate collaborations > Search > Home  
        McGovern Institute for Brain Research at MIT

recent press releases

press release archive

media coverage

brain scan
newsletter

 recent releases
  2005 archive        2004 archive        2003 archive        2002 archive        2001 archive

CAMBRIDGE, MA, May 22, 2003 -- Dr. H. Robert Horvitz, a principal investigator at the McGovern Institute for Brain Research at MIT, and a team of researchers have discovered that Chondroitin Sulphate -- a major component of human cartilage and skin -- plays a significant role in the development of organs and cells in animals.  The study is reported in today's issue of Nature.

"Our paper suggests that chondroitin influences cell shape changes during the first cell division in embryos and later during organ development," said Dr. Horvitz, Koch Professor of Biology at MIT and a 2002 recipient of the Nobel Prize for Physiology or Medicine.

In their studies of the nematode Caenorhabditis elegans, the researchers found that biosynthesis of chondroitin is required for normal embryo and organ development -- in this case the organ being the nematode vulva, through which sperm and eggs pass.

"Chondroitin seems to modify cell shape from outside the cells, most likely through the molecule's ability to interact with water, leading to swelling and a pressure against the cells," said Ho-Yon Hwang, a postdoctoral associate in MIT's Department of Biology.

Chondroitin sulphate (CS) is found in cartilage and has been known to biologists for much of the 20th century, but has not been considered an important player in development. CS is secreted to outside the cell and is a member of a group of sugar-polymers called glycosaminoglycans.  In humans, large amounts of CS are present in the extracellular matrix of cartilage, where CS plays a structural role. A modified form of CS called dermatan is a major component of skin.

Mutations in the biosynthesis of CS, dermatan and other glycocaminoglycans have been implicated in human diseases, such as an aging variant of the connective-tissue disorder Ehlers-Danlos syndrome, which is characterized by prematurely aged appearance, too-flexible joints and loose skin.  A better understanding of the biological roles of genes required for the biosynthesis of glycosaminoglycans could lead to diagnosis and better understanding of this aging disease and other similar diseases.

In addition to Hwang and Horvitz, authors include Sara Olson and Jeffrey Esko of the Glycobiology Research and Training Center at the University of California at San Diego. The study was supported by the National Institutes of Health and by the Howard Hughes Medical Institute.

Contact: Lyn Chamberlin, skyemedia, inc., 978.443.0400 x11 lyn@skyepr.com

 

 

 



© 2003 - 2008 McGovern Institute
Building 46-3160, MIT, Cambridge, MA 02139 617.324.0639 mcgovern@mit.edu
Site concept and design by Sametz Blackstone Associates